Lyxor Americas Promotes Kunjal K. Shah To Chief Investment Officer
Lyxor Americas, the U.S. subsidiary of Lyxor Asset Management, has appointed Kunjal Shah as Chief Investment Officer. Shah brings more than 20 of experience in hedge fund manager selection, investment due diligence and monitoring to the position. In his new role, Shah will further develop Lyxor Americas’ investment offering to respond to increasing client demand for advice and customized hedge fund solutions.
Shah joined Lyxor Americas in August 2014 as Global Head of Hedge Fund Research from Arden Asset Management, where he was a Partner and Managing Director. Prior to that, he was a Director and Co-Head of Hedge Fund Credit Risk Management for the Americas at Deutsche Bank. He was also member of the Hedge Fund credit team at Goldman Sachs & Co. in New York, where he led due diligence and monitoring.
Andrew Dabinett, CEO of Lyxor Americas, said: “Kunjal’s extensive capital markets experience and knowledge of hedge fund strategies is well respected by clients and industry participants alike. Kunjal is a key member of the team leading our global effort to help clients improve outcomes in their hedge fund investments.”
Shah, said: “After nearly 6 years at Lyxor Americas, I’m delighted to take up the mantle as CIO. I am thrilled to continue to work with my colleagues in the U.S. and globally to bring Lyxor’s distinctive alternative investment capabilities and solutions to clients. I am proud of what Lyxor has accomplished in the dedicated managed account and advisory space, and look forward to expanding those offerings.”
Lyxor Americas was established in 1999 and is comprised of hedge fund research, due diligence, risk, portfolio management, and structuring teams that provide fiduciary management services and help clients allocate to alternative strategies effectively.
© The Sortino Group Ltd
All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.